Overview
Dr. Friedman is the King Fahd Professor of Oncology and Professor of Pediatrics at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. He received his M.D. from the Harvard Medical School (1983), did his pediatric internship and residency at Boston Children's Hospital (1983-86), and completed a fellowship in pediatric hematology-oncology at Johns Hopkins (1986-89). As a fellow, he did post-doctoral research at the Carnegie Institution Department of Embryology located on the Johns Hopkins Homewood campus. Dr. Friedman has served on the Pediatric Oncology faculty at Johns Hopkins since 1989. His laboratory focuses on investigation of normal and abnormal blood-cell formation. Dr. Friedman also cares for children with cancer, specializing in the treatment of leukemia.
Dr. Friedman is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Leukemia, Glioma, Acute Lymphoblastic Leukemia (ALL), and Neuroblastoma.
His clinical research consists of co-authoring 33 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
Locations
1800 Orleans Street, Bloomberg 11N, Bloomberg 11N, Baltimore, MD 21287
Additional Areas of Focus
Dr. Friedman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Children's Hospital
Michael Guerrera is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Guerrera is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Hemophilia A, Blood Clots, Hemophilia B, and Hemophilic Arthropathy.
Children's Hospital
Suvankar Majumdar is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Majumdar is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.
Regina Macatangay is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. Macatangay is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Hemoglobin SC Disease, Sickle Cell Disease, Anemia, and Acute Lymphoblastic Leukemia (ALL).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Friedman isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Embryonal Tumor with Multilayered RosettesDr. Friedman isExperienced. Learn about Embryonal Tumor with Multilayered Rosettes.
- GliomaDr. Friedman isExperienced. Learn about Glioma.
- Hodgkin LymphomaDr. Friedman isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaDr. Friedman isExperienced. Learn about Leukemia.
- NeuroblastomaDr. Friedman isExperienced. Learn about Neuroblastoma.